WEBSITECHANGES

Website Changes

---

05/04/2026

Webinar next week!

---

04/27/2026

Brown Health researchers identify key molecule behind `exceptional responders` with glioblastoma

---

04/27/2026

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial

---

04/27/2026

5th Annual Tumor Takedown Event in Florida!

---

04/20/2026

IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma

---

04/13/2026

Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model

---

04/13/2026

Wearable Technology`s Growing Role in Monitoring Brain Health

---

04/13/2026

Mayo Clinic experimental dual-drug nanotherapy crosses the blood-brain barrier and improved survival in preclinical glioblastoma models

---

04/13/2026

GCAR and Purdue Pharma L.P. Announce Initiation of Tinostamustine in GBM AGILE Trial

---

04/06/2026

Brain Organoid Models Pave the Way for Precision Medicine for Glioblastoma

---

04/06/2026

Musella Foundation Supports New Glioblastoma Research Through Venture Philanthropy Grant

---

04/06/2026

Vorasidenib approved for NHS use in England

---

04/06/2026

Plixorafenib Receives FDA BTD for BRAF V600E-Mutated High Grade Glioma

---

04/06/2026

Clinical Trial For Brain Cancer Treatment Has Promising Results

---

04/06/2026

Musella Foundation Supports New Glioblastoma Research Through Venture Philanthropy Grant to KiraGen Bio

---

04/06/2026

Next-generation immunotherapy biologics for glioblastoma

---

03/30/2026

Expanding the molecular grading criteria in IDH-mutant astrocytoma

---

03/23/2026

Hoops for Hannah: a March Madness Bracket Contest!

---

03/23/2026

Brain tumors hijack sugar metabolism to evade immune attack

---

03/23/2026

Hope for the Future!

---

03/23/2026

Berzosertib enhances the sensitivity of pediatric diffuse midline glioma H3K27-altered cells to radiotherapy

---

03/12/2026

Musella Foundation Copayment Assistance Program Now Closed

---

03/02/2026

FDA Launches Framework for Accelerating Development of Individualized Therapies for Ultra-Rare Diseases

---

03/02/2026

$434,000 Awarded for Brain Tumor Research in 2026

---

03/02/2026

Tumor Treating Fields (TTFields) Therapy to be Covered for Patients with Newly Diagnosed Glioblastoma in British Columbia

---